Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BNTX
BNTX logo

BNTX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

BNTX News

mRNA Vaccine Stocks Rise as HHS Committee Revises Recommendations

Mar 11 2026seekingalpha

Serve Robotics Shares Surge After Strong Q4 Results and Upgraded Sales Guidance

Mar 11 2026Benzinga

BioNTech Q4 2025 Earnings Call Insights

Mar 10 2026seekingalpha

BioNTech Stock Plummets Amid Revenue Concerns

Mar 10 2026Benzinga

BioNTech's Disappointing Guidance Leads to Share Price Plunge

Mar 10 2026Fool

Hims & Hers Shares Rise, BioNTech Crashes Amid Leadership Changes

Mar 10 2026CNBC

U.S. Stocks Mixed in Morning Trading

Mar 10 2026Benzinga

BioNTech's Strategic Shift and Clinical Progress

Mar 10 2026Benzinga

BNTX Events

03/16 18:50
Boston Judge Backs Medical Groups Against HHS Policy Changes
Bostong U.S. District Judge Brian Murphy on Monday has sided with medical groups who argued that HHS Secretary Kennedy and the agencies he oversees have unlawfully altered federal policies, which will result in an increase for barriers to getting vaccinated, New York Times reports. The ruling suggests that the federal government had not based its decisions on science in limiting the shots. Publicly traded companies that could be impacted include Moderna (MRNA), Pfizer (PFE), BioNTech (BNTX), Novavax (NVAX), AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY), and Sanofi (SNY).

BNTX Monitor News

BioNTech stock declines despite positive mRNA vaccine recommendations

Mar 18 2026

BioNTech to Launch Independent mRNA Company by 2026

Mar 10 2026

CDC Meeting Raises Concerns Over Vaccine Safety

Mar 03 2026

Goldman Sachs Upgrades BioNTech to Buy, Raises Price Target

Jan 22 2026

Goldman Sachs Upgrades BioNTech to Buy, Raises Price Target

Jan 21 2026

BioNTech to Advance Oncology Strategy with Strong Financial Backing

Jan 13 2026

Biontech SE rises on market strength and reaches 20-day high

Jan 07 2026

BioNTech SE Drops on FDA Vaccine Safety Concerns

Dec 01 2025

BNTX Earnings Analysis

BioNTech SE Earnings Report: Strategic Growth in 2025- Intellectia AI™
4 months ago
BioNTech Reports Third Quarter 2024 Financial Results
1 years ago

People Also Watch